NM_001349206.2:c.1886+3405G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001349206.2(LPIN1):​c.1886+3405G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.11 in 152,150 control chromosomes in the GnomAD database, including 1,006 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.11 ( 1006 hom., cov: 32)

Consequence

LPIN1
NM_001349206.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.177

Publications

1 publications found
Variant links:
Genes affected
LPIN1 (HGNC:13345): (lipin 1) This gene encodes a magnesium-ion-dependent phosphatidic acid phosphohydrolase enzyme that catalyzes the penultimate step in triglyceride synthesis including the dephosphorylation of phosphatidic acid to yield diacylglycerol. Expression of this gene is required for adipocyte differentiation and it also functions as a nuclear transcriptional coactivator with some peroxisome proliferator-activated receptors to modulate expression of other genes involved in lipid metabolism. Mutations in this gene are associated with metabolic syndrome, type 2 diabetes, acute recurrent rhabdomyolysis, and autosomal recessive acute recurrent myoglobinuria (ARARM). This gene is also a candidate for several human lipodystrophy syndromes. [provided by RefSeq, Mar 2017]
LPIN1 Gene-Disease associations (from GenCC):
  • myoglobinuria, acute recurrent, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
  • hereditary recurrent myoglobinuria
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.138 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001349206.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LPIN1
NM_001349206.2
MANE Select
c.1886+3405G>A
intron
N/ANP_001336135.1Q14693-3
LPIN1
NM_001261428.3
c.2033+3405G>A
intron
N/ANP_001248357.1Q14693-7
LPIN1
NM_001349207.2
c.1976+3405G>A
intron
N/ANP_001336136.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LPIN1
ENST00000674199.1
MANE Select
c.1886+3405G>A
intron
N/AENSP00000501331.1Q14693-3
LPIN1
ENST00000256720.6
TSL:1
c.1778+3405G>A
intron
N/AENSP00000256720.2Q14693-1
LPIN1
ENST00000404113.6
TSL:1
n.1371+3405G>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.110
AC:
16779
AN:
152034
Hom.:
1007
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0547
Gnomad AMI
AF:
0.0910
Gnomad AMR
AF:
0.110
Gnomad ASJ
AF:
0.128
Gnomad EAS
AF:
0.0869
Gnomad SAS
AF:
0.0797
Gnomad FIN
AF:
0.154
Gnomad MID
AF:
0.165
Gnomad NFE
AF:
0.140
Gnomad OTH
AF:
0.131
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.110
AC:
16776
AN:
152150
Hom.:
1006
Cov.:
32
AF XY:
0.109
AC XY:
8073
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.0546
AC:
2266
AN:
41494
American (AMR)
AF:
0.110
AC:
1687
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.128
AC:
446
AN:
3472
East Asian (EAS)
AF:
0.0869
AC:
450
AN:
5180
South Asian (SAS)
AF:
0.0794
AC:
383
AN:
4826
European-Finnish (FIN)
AF:
0.154
AC:
1627
AN:
10574
Middle Eastern (MID)
AF:
0.163
AC:
48
AN:
294
European-Non Finnish (NFE)
AF:
0.140
AC:
9512
AN:
68000
Other (OTH)
AF:
0.130
AC:
274
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
765
1531
2296
3062
3827
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
192
384
576
768
960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.117
Hom.:
412
Bravo
AF:
0.105
Asia WGS
AF:
0.0750
AC:
262
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
9.4
DANN
Benign
0.96
PhyloP100
-0.18
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17603755; hg19: chr2-11939018; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.